Pesquisas alternativas:
elderly compare » elderly compared (Expandir a Pesquisa), elderly comparing (Expandir a Pesquisa), elderly complete (Expandir a Pesquisa)
may newly » a newly (Expandir a Pesquisa), men newly (Expandir a Pesquisa)
chimp can » chip can (Expandir a Pesquisa), chirp can (Expandir a Pesquisa), camp can (Expandir a Pesquisa)
2 elderly » a elderly (Expandir a Pesquisa), do elderly (Expandir a Pesquisa), 19 elderly (Expandir a Pesquisa)
compare a » compare _ (Expandir a Pesquisa)
com may » com mary (Expandir a Pesquisa), com ma (Expandir a Pesquisa), com mag (Expandir a Pesquisa)
m com » m como (Expandir a Pesquisa), m comp (Expandir a Pesquisa), e com (Expandir a Pesquisa)
3 nac » 3 nacl (Expandir a Pesquisa), _ nac (Expandir a Pesquisa), a nac (Expandir a Pesquisa)
a now » a new (Expandir a Pesquisa), a non (Expandir a Pesquisa), _ now (Expandir a Pesquisa)
elderly compare » elderly compared (Expandir a Pesquisa), elderly comparing (Expandir a Pesquisa), elderly complete (Expandir a Pesquisa)
may newly » a newly (Expandir a Pesquisa), men newly (Expandir a Pesquisa)
chimp can » chip can (Expandir a Pesquisa), chirp can (Expandir a Pesquisa), camp can (Expandir a Pesquisa)
2 elderly » a elderly (Expandir a Pesquisa), do elderly (Expandir a Pesquisa), 19 elderly (Expandir a Pesquisa)
compare a » compare _ (Expandir a Pesquisa)
com may » com mary (Expandir a Pesquisa), com ma (Expandir a Pesquisa), com mag (Expandir a Pesquisa)
m com » m como (Expandir a Pesquisa), m comp (Expandir a Pesquisa), e com (Expandir a Pesquisa)
3 nac » 3 nacl (Expandir a Pesquisa), _ nac (Expandir a Pesquisa), a nac (Expandir a Pesquisa)
a now » a new (Expandir a Pesquisa), a non (Expandir a Pesquisa), _ now (Expandir a Pesquisa)
1
Por Khasraw, M, McDonald, K, Yip, S, Verhaak, R G, Heimberger, A B, Hall, M, Barnes, E, Hovey, E, Ellingson, B M, Lwin, Z
Publicado no Neuro Oncol (2018)
“... + nivolumab to be superior to warrant further investigation. This phase II design may be converted to a larger...”Publicado no Neuro Oncol (2018)
Obter o texto integral
Obter o texto integral
Artigo
2
Por Le Rhun, E, Genbrugge, E, Stupp, R, Chinot, O L, Nabors, L B, Cloughesy, T, Reardon, D A, Wick, W, Gorlia, T, Weller, M
Publicado no Neuro Oncol (2018)
“... of maintenance TMZ chemotherapy (period II) by pooling data of three randomized clinical trials in newly...”Publicado no Neuro Oncol (2018)
Obter o texto integral
Obter o texto integral
Artigo
3
Por Grinsdale Jennifer, Marseille Elliot, Lewis Bryan, Porco Travis C, Flood Jennifer M, Royce Sarah E
Publicado em 2006-06-01
“... as tuberculosis suspects through overseas screening.</p> <p>Methods</p> <p>Using a stochastic simulation...”Publicado em 2006-06-01
Obter o texto integral
Artigo
4
Por Shin, Sanghyuk S, Modongo, Chawangwa, Baik, Yeonsoo, Allender, Christopher, Lemmer, Darrin, Colman, Rebecca E, Engelthaler, David M, Warren, Robin M, Zetola, Nicola M
Publicado no J Infect Dis (2018)
“... with drug-resistant and drug-susceptible strains) may explain the higher risk of poor tuberculosis treatment...”Publicado no J Infect Dis (2018)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
5
Por Choi, Seung Hee, Terrell, Jeffrey E., Bradford, Carol R., Ghanem, Tamer, Spector, Matthew E., Wolf, Gregory T., Lipkus, Isaac M., Duffy, Sonia A.
Publicado no Nicotine Tob Res (2016)
“... newly diagnosed head and neck cancer patients with a median follow-up time of 1627 days (N = 590...”Publicado no Nicotine Tob Res (2016)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
6
Por M. Binkhorst, J M Th Draaisma, Y. Benthem, E. M. R. van de Pol, M. Hogeveen, E. C. T. H. Tan
Publicado em 2020-11-01
“... of approximately 15 students. Directly after this training, self-efficacy was assessed with a newly developed...”Publicado em 2020-11-01
Obter o texto integral
Artigo
7
“... uses new digital signal generation technology to reduce the size and weight to ~ 1.2 Kg (2.7 pounds...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
8
Por Tan, P, Ukos, M, Miller, C, Lombardi, J, Kelly, E M
Publicado no J Can Assoc Gastroenterol (2020)
“... information extracted. RESULTS: Average MELD-Na on admission was 16.2 (sd=6.7). 14.8% of patients had a...”Publicado no J Can Assoc Gastroenterol (2020)
Obter o texto integral
Obter o texto integral
Artigo
9
Por Diefenbach, Michael A, Benedict, Catherine, Miller, Suzanne M, Stanton, Annette L, Ropka, Mary E, Wen, Kuang-Yi, Fleisher, Linda G, Mohamed, Nihal E, Hall, Simon J
Publicado no Transl Behav Med (2018)
“... support (intervention, M = 34.8, SD = 15.7; comparison, M = 38.3, SD = 16.1; F[1,337] = 3.74, p = .05...”Publicado no Transl Behav Med (2018)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
10
Por Le Rhun, E, Devos, P, Houillier, C, Cartalat-Carel, S, Chinot, O, Di Stefano, A, Reyns, N, Dubois, F, Weller, M
Publicado no Neuro Oncol (2018)
“...BACKGROUND: Thrombocytopenia is a major adverse event of temozolomide (TMZ) chemotherapy. It may...”Publicado no Neuro Oncol (2018)
Obter o texto integral
Obter o texto integral
Artigo
11
“... TAs consist of 2 opposing pairs of TAs having ceramic disks arranged within a white adhesive bandage...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
12
Por Yap, May Lin, McFadyen, James D, Wang, Xiaowei, Ziegler, Melanie, Chen, Yung-Chih, Willcox, Abbey, Nowell, Cameron J, Scott, Andrew M, Sloan, Erica K, Hogarth, P Mark, Pietersz, Geoffrey A, Peter, Karlheinz
Publicado no Theranostics (2019)
“... on activated platelets. 2) A highly potent microtubule inhibitor, monomethyl auristatin E. 3) A drug activation...”Publicado no Theranostics (2019)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
13
Por Noel, P, Wang, C, Finley, E, Espinoza, S, Bollinger, M, Parchman, M, Hazuda, H
Publicado no Innov Aging (2018)
“... associated with reductions of 0.57% in HbA1c (p=0.005) and 0.68 kg/m2 in BMI (p=0.046) at follow-up...”Publicado no Innov Aging (2018)
Obter o texto integral
Obter o texto integral
Artigo
14
Por Gupta, M., Stenson, M., O'Byrne, M., Maurer, M. J., Habermann, T., Cerhan, J. R., Weiner, G. W., Witzig, T. E.
Publicado no Ann Oncol (2016)
“..., and have a poor prognosis. New biomarkers are needed to predict prognosis and to provide insights...”Publicado no Ann Oncol (2016)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
15
Por Eliel Ruiz-May, Alma Altúzar-Molina, José M. Elizalde-Contreras, Jiovanny Arellano-de los Santos, Juan Monribot-Villanueva, Larissa Guillén, Mirna Vázquez-Rosas-Landa, Enrique Ibarra-Laclette, Mónica Ramírez-Vázquez, Rafael Ortega, Martín Aluja
Publicado em 2020-10-01
“... stages to a proteinaceous attractant, we studied antennal morphology and comparative proteomic profiles...”Publicado em 2020-10-01
Obter o texto integral
Artigo
16
“... the effects of different populations of miRNAs in these two cell classes. Specifically, miRs-28-3p, -150, -223...”
Obter o texto integral
Obter o texto integral
Artigo
17
Por Berndsen, Christopher E, Tsubota, Toshiaki, Lindner, Scott E, Lee, Susan, Holton, James M, Kaufman, Paul D, Keck, James L, Denu, John M
Publicado em 2008
“..., functions with the histone chaperone Asf1 to acetylate lysine K56 on histone H3 (H3K56), a modification...”Publicado em 2008
Obter o texto integral
Obter o texto integral
Artigo
18
Por Soto, Jamie E., Burnett, Colin M.L., Eyck, Patrick Ten, Abel, E. Dale, Grobe, Justin L.
Publicado no Obesity (Silver Spring) (2019)
“... the same room of a newly constructed animal research facility, in a crossover design study. Phenotypes were...”Publicado no Obesity (Silver Spring) (2019)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
19
Por E. Kaigorodova, N. Tarabanovskaya, E. Simolina, V. Perelmuter, M. Stakheeva, N. Cherdyntseva, O. Saveleva, L. Tashireva
Publicado em 2015-11-01
“...; luminal B-1, -2, triple negative (basal-like subtype included), HER2 positive breast cancer; T2-4N0-3M0...”Publicado em 2015-11-01
Obter o texto integral
Artigo
20
Por Linda M. Liau, Keyoumars Ashkan, David D. Tran, Jian L. Campian, John E. Trusheim, Charles S. Cobbs, Jason A. Heth, Michael Salacz, Sarah Taylor, Stacy D. D’Andre, Fabio M. Iwamoto, Edward J. Dropcho, Yaron A. Moshel, Kevin A. Walter, Clement P. Pillainayagam, Robert Aiken, Rekha Chaudhary, Samuel A. Goldlust, Daniela A. Bota, Paul Duic, Jai Grewal, Heinrich Elinzano, Steven A. Toms, Kevin O. Lillehei, Tom Mikkelsen, Tobias Walbert, Steven R. Abram, Andrew J. Brenner, Steven Brem, Matthew G. Ewend, Simon Khagi, Jana Portnow, Lyndon J. Kim, William G. Loudon, Reid C. Thompson, David E. Avigan, Karen L. Fink, Francois J. Geoffroy, Scott Lindhorst, Jose Lutzky, Andrew E. Sloan, Gabriele Schackert, Dietmar Krex, Hans-Jorg Meisel, Julian Wu, Raphael P. Davis, Christopher Duma, Arnold B. Etame, David Mathieu, Santosh Kesari, David Piccioni, Manfred Westphal, David S. Baskin, Pamela Z. New, Michel Lacroix, Sven-Axel May, Timothy J. Pluard, Victor Tse, Richard M. Green, John L. Villano, Michael Pearlman, Kevin Petrecca, Michael Schulder, Lynne P. Taylor, Anthony E. Maida, Robert M. Prins, Timothy F. Cloughesy, Paul Mulholland, Marnix L. Bosch
Publicado em 2018-05-01
“... with methylated MGMT (n = 131), mOS was 34.7 months from surgery, with a 3-year survival of 46.4...”Publicado em 2018-05-01
Obter o texto integral
Artigo